Document Detail

The growth hormone secretagogue hexarelin increases cell proliferation in neurogenic regions of the mouse hippocampus.
MedLine Citation:
PMID:  19800825     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Radiation therapy (RT) to the brain is often used in the treatment of children with different types of malignant diseases affecting the brain. However, RT in childhood may also have severe side effects including impaired brain maturation and intellectual development. For childhood cancer survivors these adverse effects of RT can cause lifelong disability and suffering. Therefore, there is an unmet need to limit late effects after RT. Precursor cells in the subgranular zone of the dentate gyrus (DG) in the hippocampus are particularly sensitive to irradiation (IR). This may be of significance as newly generated neurons in the DG are important for memory and learning. GH secretagogues (GHS) have previously been shown to promote neurogenesis and to have neuroprotective effects. In addition, several parts of the brain, including the hippocampus, have been shown to express the GHS receptor 1a (GHS-R1a). The aim of this study was to evaluate the potential effect of the GHS hexarelin on proliferation and survival of progenitor cells in the hippocampus after brain IR in a mouse model.
DESIGN: In the present study, 10-day-old male mice received 6Gy cranial IR. Non-irradiated sham animals were used as controls. We treated one group of irradiated and one sham group with hexarelin (100microg/kg/day) for 28days and used immunohistochemical labeling of bromo-deoxy uridine (BrdU) and phospho-histone H3 of the granular cell layer of the DG to evaluate proliferation and cell survival after IR at postnatal day ten.
RESULTS: Our results show that hexarelin significantly increased the number of BrdU-positive cells in the granule cell layer by approximately 50% compared to controls.
CONCLUSION: The increased number of BrdU-positive cells in the granule cell layer suggests a partial restoration in the pool of proliferating cells by hexarelin after IR.
Anna Barlind; Niklas Karlsson; N David Åberg; Thomas Björk-Eriksson; Klas Blomgren; Jörgen Isgaard
Related Documents :
3302535 - Novel monocyte-like properties of microglial/astroglial cells. constitutive secretion o...
19242525 - Lentiviral vectors for gene transfer into the spinal cord glial cells.
19384335 - Tat-hsp70-mediated neuroprotection and increased survival of neuronal precursor cells a...
7869095 - Migratory paths of neurons and glia in the embryonic chick spinal cord.
9461095 - Immortalized rat proximal tubule cells produce membrane bound and soluble megalin.
24966905 - Permeability of rhynchophylline across human intestinal cell in vitro.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-10-02
Journal Detail:
Title:  Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society     Volume:  20     ISSN:  1532-2238     ISO Abbreviation:  Growth Horm. IGF Res.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-04-09     Revised Date:  2011-01-12    
Medline Journal Info:
Nlm Unique ID:  9814320     Medline TA:  Growth Horm IGF Res     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  49-54     Citation Subset:  IM    
Copyright Information:
Copyright 2009 Elsevier Ltd. All rights reserved.
Laboratory of Experimental Endocrinology, Department of Internal Medicine, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain / drug effects,  radiation effects
Cell Proliferation / drug effects*
Cell Survival / drug effects,  radiation effects
Dentate Gyrus / drug effects*,  radiation effects
Histones / drug effects
Mice, Inbred C57BL
Neurogenesis / drug effects*
Neuroprotective Agents / pharmacology*
Oligopeptides / pharmacology*
Radiation-Protective Agents / pharmacology*
Reg. No./Substance:
0/Histones; 0/Neuroprotective Agents; 0/Oligopeptides; 0/Radiation-Protective Agents; 140703-51-1/hexarelin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Image reconstructions with the rotating RF coil.
Next Document:  Management of phenylketonuria in Europe: Survey results from 19 countries.